{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:57:36Z","timestamp":1786118256568,"version":"build-2736575974"},"posted":{"date-parts":[[2026,8,4]]},"group-title":"Neuroscience","reference-count":67,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"award":["R01AG061038"],"award-info":[{"award-number":["R01AG061038"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["R01AG071682"],"award-info":[{"award-number":["R01AG071682"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["R01AG082273"],"award-info":[{"award-number":["R01AG082273"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["Internal Awards"],"award-info":[{"award-number":["Internal Awards"]}],"id":[{"id":"https:\/\/ror.org\/001tmjg57","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Human\n                  <jats:italic>APOE4<\/jats:italic>\n                  is the strongest genetic risk factor for late-onset Alzheimer\u2019s disease (AD), whereas the relatively rare\n                  <jats:italic>APOE2<\/jats:italic>\n                  confers exceptional protection. This study examines whether recombinant ApoE2 protein can therapeutically leverage this genetic advantage to strengthen aging brains at risk for AD. We produced recombinant human ApoE2 (rhApoE2) using the FreeStyle 293-F system, yielding rhApoE2 with extensive sialylation that closely resembles its natural form in the human brain. In ApoE4-knockin mouse primary neurons, exposure to rhApoE2 induced significant increases in hexokinase 2 expression and decreases in endogenous ApoE4 protein levels. rhApoE2 also protected ApoE4 neurons from oligomeric amyloid-\u03b2 toxicity and oxidative stress. We further developed a cadherin-derived peptide (ADTC5) that transiently increases paracellular porosity of the blood-brain barrier, enabling safe, non-invasive delivery of rhApoE2 into the mouse brain. When co-administered with ADTC5, weekly intravenous doses of rhApoE2 for 4-8 weeks in middle-aged and aged ApoE4 mice enhanced synaptosomal glycolytic and exocytotic activities, promoted cortical lipid metabolic dynamics and DHA utilization, and improved learning and memory, with sex differences observed in some outcomes. These findings offer preliminary evidence supporting the therapeutic potential of human brain-like rhApoE2 sialoprotein, which enhances metabolic robustness and cognitive strength in aging ApoE4 brains, possibly modulated by sex.\n                <\/jats:p>","DOI":"10.64898\/2026.07.30.741628","type":"posted-content","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:50:20Z","timestamp":1785909020000},"source":"Crossref","is-referenced-by-count":0,"title":["Recombinant sialylated ApoE2 suppresses ApoE4 and sex-specifically strengthens brain metabolism and cognition in ApoE4 mice"],"prefix":"10.64898","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS 66045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Jung","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS 66045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruna","family":"Siahaan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, KS 66045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS 66045, USA"},{"name":"Neuroscience Graduate Program, University of Kansas, Lawrence, KS 66045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"issue":"3","key":"2026080608250587000_2026.07.30.741628v1.1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","article-title":"Evidence for brain glucose dysregulation in Alzheimer\u2019s disease","volume":"14","year":"2018","journal-title":"Alzheimers Dement"},{"key":"2026080608250587000_2026.07.30.741628v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-019-0132-6"},{"key":"2026080608250587000_2026.07.30.741628v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2018.03.014"},{"key":"2026080608250587000_2026.07.30.741628v1.4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019191"},{"issue":"1","key":"2026080608250587000_2026.07.30.741628v1.5","doi-asserted-by":"crossref","first-page":"ENEURO.0389-18.2019","DOI":"10.1523\/ENEURO.0389-18.2019","article-title":", Aerobic Glycolysis Is Required for Spatial Memory Acquisition But Not Memory Retrieval in Mice","volume":"6","year":"2019","journal-title":"eneuro"},{"key":"2026080608250587000_2026.07.30.741628v1.6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.8.1467"},{"key":"2026080608250587000_2026.07.30.741628v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/ng0694-180"},{"key":"2026080608250587000_2026.07.30.741628v1.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14279-8"},{"key":"2026080608250587000_2026.07.30.741628v1.9","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3266-12.2012"},{"key":"2026080608250587000_2026.07.30.741628v1.10","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.4.442"},{"key":"2026080608250587000_2026.07.30.741628v1.11","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000147469.18313.3B"},{"key":"2026080608250587000_2026.07.30.741628v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.05.030"},{"key":"2026080608250587000_2026.07.30.741628v1.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603213341202"},{"key":"2026080608250587000_2026.07.30.741628v1.14","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2262-17.2018"},{"key":"2026080608250587000_2026.07.30.741628v1.15","doi-asserted-by":"crossref","unstructured":"Zhang, X. , et al., Opposing Effects of ApoE2 and ApoE4 on Glycolytic Metabolism in Neuronal Aging Supports a Warburg Neuroprotective Cascade against Alzheimer\u2019s Disease. Cells, 2023. 12(3).","DOI":"10.3390\/cells12030410"},{"key":"2026080608250587000_2026.07.30.741628v1.16","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1399965"},{"key":"2026080608250587000_2026.07.30.741628v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105631"},{"key":"2026080608250587000_2026.07.30.741628v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-021-00851-3"},{"issue":"3","key":"2026080608250587000_2026.07.30.741628v1.19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s43587-023-00368-3","article-title":"Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits","volume":"3","year":"2023","journal-title":"Nat Aging"},{"key":"2026080608250587000_2026.07.30.741628v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(01)00046-X"},{"key":"2026080608250587000_2026.07.30.741628v1.21","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201709069"},{"key":"2026080608250587000_2026.07.30.741628v1.22","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-008-9018-7"},{"key":"2026080608250587000_2026.07.30.741628v1.23","doi-asserted-by":"crossref","unstructured":"Ulapane, K.R. , B.M. Kopec , and T.J. Siahaan , Improving In Vivo Brain Delivery of Monoclonal Antibody Using Novel Cyclic Peptides. Pharmaceutics, 2019. 11(11).","DOI":"10.3390\/pharmaceutics11110568"},{"issue":"12","key":"2026080608250587000_2026.07.30.741628v1.24","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1021\/acs.molpharmaceut.9b00763","article-title":"In Vivo Brain Delivery and Brain Deposition of Proteins with Various Sizes","volume":"16","year":"2019","journal-title":"Mol Pharm"},{"key":"2026080608250587000_2026.07.30.741628v1.25","doi-asserted-by":"crossref","first-page":"149751","DOI":"10.1016\/j.brainres.2025.149751","article-title":"Acute high glucose exposure impairs synaptosomal vesicle release activity","volume":"1863","year":"2025","journal-title":"Brain Res"},{"issue":"2","key":"2026080608250587000_2026.07.30.741628v1.26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-122341","article-title":"Early intervention with an estrogen receptor \u03b2-selective phytoestrogenic formulation prolongs survival, improves spatial recognition memory, and slows progression of amyloid pathology in a female mouse model of Alzheimer\u2019s disease","volume":"37","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"2026080608250587000_2026.07.30.741628v1.27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tem.2023.05.002","article-title":"Apolipoprotein E in lipid metabolism and neurodegenerative disease","volume":"34","year":"2023","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"2026080608250587000_2026.07.30.741628v1.28","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1368839"},{"issue":"4","key":"2026080608250587000_2026.07.30.741628v1.29","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3233\/JAD-230543","article-title":"Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer\u2019s Disease","volume":"95","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"2026080608250587000_2026.07.30.741628v1.30","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24135"},{"key":"2026080608250587000_2026.07.30.741628v1.31","doi-asserted-by":"crossref","unstructured":"Zhang, X. , et al., Chapter 7 - Sporadic Alzheimer\u2019s triad: age, sex, and ApoE, in Assessments, Treatments and Modeling in Aging and Neurological Disease, C.R. Martin , V.R. Preedy , and R. Rajendram , Editors. 2021, Academic Press. p. 65\u201377.","DOI":"10.1016\/B978-0-12-818000-6.00007-X"},{"key":"2026080608250587000_2026.07.30.741628v1.32","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26043"},{"key":"2026080608250587000_2026.07.30.741628v1.33","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25455"},{"key":"2026080608250587000_2026.07.30.741628v1.34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI96429"},{"key":"2026080608250587000_2026.07.30.741628v1.35","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0033-12.2012"},{"issue":"10","key":"2026080608250587000_2026.07.30.741628v1.36","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1038\/s41380-020-00956-4","article-title":"C\/EBP\u03b2 is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer\u2019s disease","volume":"26","year":"2021","journal-title":"Molecular Psychiatry"},{"key":"2026080608250587000_2026.07.30.741628v1.37","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0646-14.2014"},{"key":"2026080608250587000_2026.07.30.741628v1.38","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007000"},{"key":"2026080608250587000_2026.07.30.741628v1.39","doi-asserted-by":"publisher","DOI":"10.1111\/gtc.12730"},{"key":"2026080608250587000_2026.07.30.741628v1.40","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1038\/mtna.2015.37","article-title":"Off-target Effects in CRISPR\/Cas9-mediated Genome Engineering","volume":"4","year":"2015","journal-title":"Molecular Therapy - Nucleic Acids"},{"issue":"9","key":"2026080608250587000_2026.07.30.741628v1.41","doi-asserted-by":"crossref","first-page":"2100040","DOI":"10.1002\/adtp.202100040","article-title":"Engineering Gene Therapy: Advances and Barriers","volume":"4","year":"2021","journal-title":"Advanced Therapeutics"},{"key":"2026080608250587000_2026.07.30.741628v1.42","doi-asserted-by":"crossref","first-page":"648617","DOI":"10.3389\/fnins.2021.648617","article-title":"Sialometabolism in Brain Health and Alzheimer\u2019s Disease","volume":"15","year":"2021","journal-title":"Front Neurosci"},{"key":"2026080608250587000_2026.07.30.741628v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.04.014"},{"key":"2026080608250587000_2026.07.30.741628v1.44","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3389\/fnins.2019.00871","article-title":"Reduction of Glycolysis Intermediate Concentrations in the Cerebrospinal Fluid of Alzheimer\u2019s Disease Patients","volume":"13","year":"2019","journal-title":"Front Neurosci"},{"key":"2026080608250587000_2026.07.30.741628v1.45","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.185"},{"issue":"2","key":"2026080608250587000_2026.07.30.741628v1.46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-150348","article-title":"Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer\u2019s Disease Prevention and Early Intervention","volume":"48","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"2026080608250587000_2026.07.30.741628v1.47","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3233\/JAD-160307","article-title":"Human ApoE \u025b2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase","volume":"53","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"2026080608250587000_2026.07.30.741628v1.48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2212256120"},{"issue":"4","key":"2026080608250587000_2026.07.30.741628v1.49","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00394-019-02126-x","article-title":"Polyunsaturated fatty acids and risk of Alzheimer\u2019s disease: a Mendelian randomization study","volume":"59","year":"2020","journal-title":"Eur J Nutr"},{"key":"2026080608250587000_2026.07.30.741628v1.50","doi-asserted-by":"crossref","unstructured":"Chu, C.S. , et al., Higher Serum DHA and Slower Cognitive Decline in Patients with Alzheimer\u2019s Disease: Two-Year Follow-Up. Nutrients, 2022. 14(6).","DOI":"10.3390\/nu14061159"},{"key":"2026080608250587000_2026.07.30.741628v1.51","doi-asserted-by":"crossref","unstructured":"Melo van Lent, D. , et al., Eicosapentaenoic Acid Is Associated with Decreased Incidence of Alzheimer\u2019s Dementia in the Oldest Old. Nutrients, 2021. 13(2).","DOI":"10.3390\/nu13020461"},{"key":"2026080608250587000_2026.07.30.741628v1.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2010.02.025"},{"key":"2026080608250587000_2026.07.30.741628v1.53","doi-asserted-by":"crossref","first-page":"1516991","DOI":"10.3389\/fphar.2025.1516991","article-title":"Sphingosine 1-phosphate receptor 1 modulators exert neuroprotective effects in central nervous system disorders","volume":"16","year":"2025","journal-title":"Front Pharmacol"},{"key":"2026080608250587000_2026.07.30.741628v1.54","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3248"},{"key":"2026080608250587000_2026.07.30.741628v1.55","doi-asserted-by":"crossref","first-page":"609679","DOI":"10.3389\/fnagi.2021.609679","article-title":"The Therapeutic Targets of Fingolimod (FTY720) Are Involved in Pathological Processes in the Frontal Cortex of Alzheimer\u2019s Disease Patients: A Network Pharmacology Study","volume":"13","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"2026080608250587000_2026.07.30.741628v1.56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1789.2004.00571.x"},{"issue":"1","key":"2026080608250587000_2026.07.30.741628v1.57","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s42003-022-04011-6","article-title":"Multi-Omic analyses characterize the ceramide\/sphingomyelin pathway as a therapeutic target in Alzheimer\u2019s disease","volume":"5","year":"2022","journal-title":"Commun Biol"},{"key":"2026080608250587000_2026.07.30.741628v1.58","doi-asserted-by":"crossref","first-page":"13082","DOI":"10.1038\/ncomms13082","article-title":"Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease","volume":"7","year":"2016","journal-title":"Nat Commun"},{"issue":"2","key":"2026080608250587000_2026.07.30.741628v1.59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s12276-024-01176-4","article-title":"Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer\u2019s disease","volume":"56","year":"2024","journal-title":"Exp Mol Med"},{"issue":"1","key":"2026080608250587000_2026.07.30.741628v1.60","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41531-025-01114-9","article-title":"Elevated hexosylceramides in Parkinson\u2019s disease cause gene upregulations in neurons mimicking responses to pathogens","volume":"11","year":"2025","journal-title":"NPJ Parkinsons Dis"},{"key":"2026080608250587000_2026.07.30.741628v1.61","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.662242"},{"key":"2026080608250587000_2026.07.30.741628v1.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2016.02.011"},{"issue":"2","key":"2026080608250587000_2026.07.30.741628v1.63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","year":"2013","journal-title":"Nature Reviews Neurology"},{"issue":"16","key":"2026080608250587000_2026.07.30.741628v1.64","first-page":"1349","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease","volume":"278","year":"1997","journal-title":"A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Jama"},{"key":"2026080608250587000_2026.07.30.741628v1.65","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0231-7"},{"key":"2026080608250587000_2026.07.30.741628v1.66","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbi.2020.05.021","article-title":"Traumatic stress history interacts with sex and chronic peripheral inflammation to alter mitochondrial function of synaptosomes. Brain","volume":"88","year":"2020","journal-title":"Behavior, and Immunity"},{"key":"2026080608250587000_2026.07.30.741628v1.67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147733"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.07.30.741628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:25:20Z","timestamp":1786029920000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.07.30.741628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":67,"URL":"https:\/\/doi.org\/10.64898\/2026.07.30.741628","relation":{},"subject":[],"published":{"date-parts":[[2026,8,4]]},"subtype":"preprint"}}